Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: Portugal Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20192
20204

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck KGaA, Darmstadt, Germany2
Actuate Therapeutics Inc.1
AstraZeneca1
Genentech, Inc.1
Incyte Corporation1
MedSIR1
Nektar Therapeutics1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis9
Breast Neoplasms3
Carcinoma, Transitional Cell2
Colorectal Neoplasms2
Neoplasms2
Acrocephalosyndactylia1
Bone Neoplasms1
Brain Neoplasms1
Glioma1
Hereditary Sensory and Autonomic Neuropathies1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.